A randomized, double-blind, multi-center study comparing the effects of carvedilol phosphate modified release formulation (Coreg-MR) with metoprolol succinate (Toprol XL) on the lipid profile in normolipidemic, or mildly dyslipidemic hypertensive patients.

Trial Profile

A randomized, double-blind, multi-center study comparing the effects of carvedilol phosphate modified release formulation (Coreg-MR) with metoprolol succinate (Toprol XL) on the lipid profile in normolipidemic, or mildly dyslipidemic hypertensive patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Carvedilol; Metoprolol
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Feb 2010 Actual number of patients (568) and actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
    • 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top